Table 2 Prevalence of viral genome detection by qPCR in nasopharyngeal swabs and tracheal washes
| Virus | Overall prevalence (95% CI) | |||
|---|---|---|---|---|
| ‘Positive’ samples | ‘Quantifiable’ samples | |||
| NS | TW | NS | TW | |
| EHV-5 |
90.9% (88.9–92.6) |
55.4% (52.3–58.5) |
58.7% (55.6–61.8) |
19.1% (16.7–21.7) |
| EHV-2 |
76.4% (73.6–79.0) |
35.4% (32.4–38.5) |
47.7% (44.6–50.8) |
14.6% (12.5–16.9) |
| ERBV |
7.8% (6.2–9.6) |
7.8% (6.2–9.6) |
2.1% (1.3–3.2) |
2.9% (2.0–4.1) |
| EHV-4 |
6.0% (4.6–7.7) |
3.8% (2.7–5.2) |
1.5% (0.8–2.5) |
1.5% (0.8–2.5) |
| EAdV1 |
3.6% (2.5–4.9) |
1.9% (1.1–3.0) |
0.2% (0.0–0.7) | neg. |
| EHV-1 |
1.9% (1.1–3.0) |
0.2% (0.0–0.7) |
0.2% (0.0–0.7) | neg. |
| ERAV | neg. |
0.2% (0.0–0.7) | neg. |
0.2% (0.0–0.7) |
| EAdV2 | neg. | neg. | neg. | neg. |
| ECoV | neg. | neg. | neg. | neg. |
| EIV | neg. | neg. | neg. | neg. |